ArticleNPJ precision oncology2024

Breast cancer brain metastases genomic profiling identifies alterations targetable by immune-checkpoint and PARP inhibitors.

A Giannoudis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.